A Review of Mixed Strain Clostridium difficile Colonization and Infection

by Pete Dayananda, Pete Dayananda, Mark H. Wilcox, Mark H. Wilcox
Published 2019-04-01

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

by Simon D. Baines, Mark H. Wilcox
Published 2015-07-01

The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome.

by Kerrie A Davies, Tim Planche, Mark H Wilcox
Published 2018-01-01

Lower Urinary Tract Infections: Management, Outcomes and Risk Factors for Antibiotic Re-prescription in Primary Care

by Mar Pujades-Rodriguez, Robert M. West, Mark H. Wilcox, Jonathan Sandoe
Published 2019-09-01

Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.

by Caroline H Chilton, Grace S Crowther, Helen Ashwin, Chris M Longshaw, Mark H Wilcox
Published 2016-01-01

Recontamination of Healthcare Surfaces by Repeated Wiping with Biocide-Loaded Wipes: “<i>One Wipe, One Surface, One Direction, Dispose</i>” as Best Practice in the Clinical Environ...

by Nicholas W. M. Edwards, Emma L. Best, Parikshit Goswami, Mark H. Wilcox, Stephen J. Russell
Published 2020-12-01

Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains.

by Janet Y Nale, Jinyu Shan, Peter T Hickenbotham, Warren N Fawley, Mark H Wilcox, Martha R J Clokie
Published 2012-01-01

Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon

by Ines B. Moura, Charmaine Normington, Duncan Ewin, Emma Clark, Mark H. Wilcox, Anthony M. Buckley, Caroline H. Chilton
Published 2020-01-01

Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.

by Grace S Crowther, Caroline H Chilton, Sharie L Todhunter, Scott Nicholson, Jane Freeman, Simon D Baines, Mark H Wilcox
Published 2014-01-01

Role of surface energy and nano-roughness in the removal efficiency of bacterial contamination by nonwoven wipes from frequently touched surfaces

by Nicholas W. M. Edwards, Emma L. Best, Simon D. Connell, Parikshit Goswami, Chris M. Carr, Mark H. Wilcox, Stephen J. Russell
Published 2017-12-01

Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland

by Andreas F. Widmer, Reno Frei, Ed J. Kuijper, Mark H. Wilcox, Ruth Schindler, Violeta Spaniol, Daniel Goldenberger, Adrian Egli, Sarah Tschudin-Sutter
Published 2020-10-01

Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of <i>Clostridium difficile</i> with a Point of Care, Polymerase Chain Reaction Test as the First...

by William S. Jones, Stephen Rice, H. Michael Power, Gregory Maniatopoulos, Jana Suklan, Fiona Beyer, Mark H. Wilcox, Michelle Permain, A. John Simpson, D. Ashley Price, A. Joy Allen
Published 2020-10-01

Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile.

by Warren N Fawley, C W Knetsch, Duncan R MacCannell, Celine Harmanus, Tim Du, Michael R Mulvey, Ashley Paulick, Lydia Anderson, E J Kuijper, Mark H Wilcox
Published 2015-01-01

Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review.

by Eroboghene H Otete, Anand S Ahankari, Helen Jones, Kirsty J Bolton, Caroline W Jordan, Tim C Boswell, Mark H Wilcox, Neil M Ferguson, Charles R Beck, Richard L Puleston
Published 2013-01-01

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineageResearch in context

by David W. Eyre, Xavier Didelot, Anthony M. Buckley, Jane Freeman, Ines B. Moura, Derrick W. Crook, Tim E.A. Peto, A. Sarah Walker, Mark H. Wilcox, Kate E. Dingle
Published 2019-05-01

Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study

by Anthony M. Buckley, Ines B. Moura, Norie Arai, William Spittal, Emma Clark, Yoshihiro Nishida, Hannah C. Harris, Karen Bentley, Georgina Davis, Dapeng Wang, Suparna Mitra, Takanobu Higashiyama, Mark H. Wilcox
Published 2021-07-01

Genetic Association Reveals Protection against Recurrence of Clostridium difficile Infection with Bezlotoxumab Treatment

by Judong Shen, Devan V. Mehrotra, Mary Beth Dorr, Zhen Zeng, Junhua Li, Xun Xu, David Nickle, Emily R. Holzinger, Aparna Chhibber, Mark H. Wilcox, Rebecca L. Blanchard, Peter M. Shaw
Published 2020-05-01

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease.

by David W Eyre, A Sarah Walker, Jane Freeman, Simon D Baines, Warren N Fawley, Caroline H Chilton, David Griffiths, Alison Vaughan, Derrick W Crook, Tim E A Peto, Mark H Wilcox
Published 2013-01-01

Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.

by A Sarah Walker, David W Eyre, David H Wyllie, Kate E Dingle, Rosalind M Harding, Lily O'Connor, David Griffiths, Ali Vaughan, John Finney, Mark H Wilcox, Derrick W Crook, Tim E A Peto
Published 2012-02-01

Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study

by Louise Pankhurst, Louissa Macfarlane-Smith, James Buchanan, Luke Anson, Kerrie Davies, Lily O’Connor, Helen Ashwin, Graham Pike, Kate E Dingle, Timothy EA Peto, Sarah Wordsworth, A Sarah Walker, Mark H Wilcox, Derrick W Crook
Published 2014-08-01